We are live on ! Find out more
NTUS

Natus Medical Inc

Delisted

NTUS was delisted on the 20th of July, 2022.

172 hedge funds and large institutions have $1.04B invested in Natus Medical Inc in 2019 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 70 increasing their positions, 42 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 42

64% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 14

54% more call options, than puts

Call options by funds: $1.56M | Put options by funds: $1.01M

2% more funds holding

Funds holding: 168172 (+4)

4% more capital invested

Capital invested by funds: $998M → $1.04B (+$37.5M)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
172
Holders Change
+4
Holders Change %
+2.38%
% of All Funds
3.39%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
23
Increased
70
Reduced
42
Closed
14
Calls
$1.56M
Puts
$1.01M
Net Calls
+$547K
Net Calls Change
-$262K
Name Holding Trade Value Shares
Change
Change in
Stake
Walleye Trading
176
Walleye Trading
New York
-$322K -10,126 Closed
CIP
177
Convergence Investment Partners
Florida
-$221K -6,946 Closed
MWNA
178
Marshall Wace North America
New York
-$180K -5,660 Closed
WC
179
Weil Company
California
-$141K -4,440 Closed
BWP
180
BSW Wealth Partners
Colorado
-$36K -1,117 Closed
PCM
181
Prelude Capital Management
New York
-$13K -400 Closed
QT
182
Quantbot Technologies
New York
-$6K -200 Closed
TRCT
183
Tower Research Capital (TRC)
New York
-$5K -160 Closed
LPWM
184
Lake Point Wealth Management
Texas
+$320 +10 New

NTUS Hedge Fund Activity: Q4 2019 in Review

172 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Natus Medical Inc (NTUS) for Q4 2019, worth a combined $1.04B — up 3.8% from $998M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new NTUS positions and 14 closed out — a net gain of 9 holders — while 70 added to existing stakes and 42 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $10.1M. The largest seller was Janus Henderson Group, cutting an estimated $37.2M.

  • 172 institutional investors held Natus Medical Inc (NTUS) as of Q4 2019, up from 168 in Q3 2019.
  • Funds reported $1.04B of Natus Medical Inc stock for Q4 2019, up 3.8% quarter-over-quarter.
  • 23 funds opened new Natus Medical Inc positions in Q4 2019 and 14 closed out, a net change of +9 holders.
  • The largest Natus Medical Inc buyer in Q4 2019 was Goldman Sachs, an estimated $10.1M added.
  • The largest Natus Medical Inc seller in Q4 2019 was Janus Henderson Group, an estimated $37.2M sold.

Based on aggregated 13F filings for Q4 2019.